Sponsor:
argenx
Code:
NCT07610564
Conditions
Multifocal Motor Neuropathy (MMN)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Empasiprubart IV
Brief summary:
Conditions
Multifocal Motor Neuropathy (MMN)
Study ID
NCT07610564
Start date
Jul 27, 2026
Status verified date
Sep, 2026
Completion date
Apr 1, 2030
Anticipated
Primary completion date
Feb 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Empasiprubart IV
Interventions
Empasiprubart IV
Primary outcome measure
Central contacts
Locations
Yale University School of Medicine
Recruiting
New Haven, Connecticut, United States, 65103221
Contacts
Sponsor
argenx
Last update posted
Nov 16, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by argenx on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.